Goldman Sachs
BNTX icon

Goldman Sachs’s BioNTech BNTX Stock Holding History

Goldman Sachs’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
+12,500
New +$1.18M ﹤0.01% 5097
2026
Q1 		– Sell
-21,900
Closed -$2.08M – 6499
2025
Q4 		$2.08M Buy
21,900
+900
+4% +$90.7K ﹤0.01% 4549
2025
Q3 		$2.07M Hold
21,000
– – ﹤0.01% 4444
2025
Q2 		$2.24M Sell
21,000
-16,900
-45% -$1.71M ﹤0.01% 4091
2025
Q1 		$3.45M Buy
37,900
+4,900
+15% +$549K ﹤0.01% 3708
2024
Q4 		$3.76M Hold
33,000
– – ﹤0.01% 3740
2024
Q3 		$3.92M Buy
33,000
+16,000
+94% +$1.47M ﹤0.01% 3567
2024
Q2 		$1.37M Buy
17,000
+11,100
+188% +$1.01M ﹤0.01% 4235
2024
Q1 		$544K Buy
+5,900
New +$566K ﹤0.01% 4711
2023
Q3 		– Sell
-20,000
Closed -$2.16M – 5555
2023
Q2 		$2.16M Hold
20,000
– – ﹤0.01% 3824
2023
Q1 		$2.49M Buy
20,000
+17,200
+614% +$2.36M ﹤0.01% 3695
2022
Q4 		$421K Hold
2,800
– – ﹤0.01% 4964
2022
Q3 		$378K Hold
2,800
– – ﹤0.01% 5158
2022
Q2 		$417K Sell
2,800
-182,800
-98% -$27.9M ﹤0.01% 5210
2022
Q1 		$31.7M Buy
185,600
+81,500
+78% +$13.7M 0.01% 1679
2021
Q4 		$26.8M Buy
104,100
+74,100
+247% +$20.3M 0.01% 1861
2021
Q3 		$8.19M Sell
30,000
-82,500
-73% -$26.2M ﹤0.01% 2915
2021
Q2 		$25.2M Buy
112,500
+102,800
+1,060% +$19.4M 0.01% 1847
2021
Q1 		$1.06M Buy
+9,700
New +$1.03M ﹤0.01% 4569
2020
Q4 		– Sell
-134,500
Closed -$9.31M – 5490
2020
Q3 		$9.31M Buy
+134,500
New +$9.65M ﹤0.01% 2390

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Goldman Sachs's BNTX Position: Q2 2026 in Review

Goldman Sachs increased its BioNTech (BNTX) stake by 509% in Q2 2026, buying an estimated $46.4M and bringing the position to 589,903 shares worth $54.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Goldman Sachs first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $84.7M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Goldman Sachs held 589,903 shares of BioNTech worth $54.9M as of Q2 2026.
  • Goldman Sachs bought 493,074 BioNTech shares in Q2 2026, an estimated $46.4M.
  • BioNTech made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1721 holding.
  • Goldman Sachs first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Goldman Sachs's BioNTech position peaked at $84.7M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.